Etropal AD

Stocks

ETR

BG1100001038

Medical Equipment, Supplies & Distribution

End-of-day quote Bulgaria S.E. 2026-08-31			5-day change	1st Jan Change
2.620 ^EUR	-1.50%		-1.50%	+14.03%

06-04	Etropal AD Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-02	Etropal AD Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Etropal : Insider information

Published on 10/08/2025 at 08:24 am EDT

Publicnow

Add MarketScreener to your sources

ETROPAL AD

-1.50%

Insider information 08.10.2025 11:32:17 (local time)

Company: Etropal AD (ETR)
Notification under Art. 19 (3) of Regulation (EU) No. 596/2014 of the European Parliament and Council of 16 April 2014
The entire piece of news is available on the financial website X3News.

Attachments

Original document
Permalink

Disclaimer

Etropal AD published this content on October 08, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 08, 2025 at 12:23 UTC.

Add MarketScreener to your sources

Latest news about Etropal AD

06-04	Etropal AD Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-02	Etropal AD Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12-01	Etropal AD Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
25-08-29	Etropal AD Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-05-22	Etropal AD Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-02-28	Etropal AD Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-10-29	Etropal AD Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
24-07-29	Etropal AD Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-05-30	Etropal AD Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-02-28	Etropal AD Reports Earnings Results for the Full Year Ended December 31, 2023	CI
23-11-29	Etropal AD Reports Earnings Results for the Nine Months Ended September 30, 2023	CI
23-08-28	Etropal AD Reports Earnings Results for the Half Year Ended June 30, 2023	CI
23-05-30	Etropal AD Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
23-03-01	Etropal AD Reports Earnings Results for the Full Year Ended December 31, 2022	CI
22-10-31	Etropal AD Reports Earnings Results for the Nine Months Ended September 30, 2022	CI

Chart Etropal AD

Duration

Period

ETR: Dynamic Chart

Company Profile

Etropal AD is a Bulgaria-based company, which specializes in the scientific research, experimental and development activities in the field of orthopedics and traumatology. The Company manufactures and offers endoprothesys and implants, special bioceramic materials and alloys for the medicine, special surgical instruments, osteosynthesys means, single use syringes, haemodialysis apparatuses and lines and single use medical materials. The Companyâ€™s product portfolio includes fiber dialyzers, arterial and venous lines for haemodialysis, transfusion and infusion sets, fistula and injection needles, catheters, tubes, and femoral implants, among others. The Company operates through one subsidiary, Etropal Trade OOD. As of December 31, 2011, the Companyâ€™s major shareholder was Sintetika AD with a stake of 66.53%.

Employees

100

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement and Estimates

More financial data